Plasma total GLP-1 levels were measured by radioimmunoassay using GLPIT-36HK (Millipore, USA), with a sensitivity of 3 pmol/l and intra- and interassay CVs of 7.9% and 12.9%
Several studies confirm that long-term treatment with non-steroidal anti-inflammatory drugs (NSAIDs) that non-selectively inhibit cyclooxygenases COX-1 and COX-2, such as ibuprofen, reduce the risk of AD by the inhibition of the inflammatory cascade [13,14,15]
Cardiometabolic Benefits GLP-1 receptor agonists improve lipid profiles, reduce inflammation, and lower blood pressure
Selected publications: Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ FEBS Letters, 1988
Mixed with 2 mL, that gives 2,500 mcg/mL